Biopharma Plastics Market Expected to Develop at a CAGR of 11.4% through 2033, totaling US$ 15.95 billion | Future Market Insights Inc.

The global biopharma plastics market is poised to reach a valuation of US$ 5.42 billion in 2023. In 2033, the market’s valuation was reached around US$ 15.95 billion. It is predicted to register a healthy CAGR of 11.4% until the end of the forecast period.

Depth filters, syringes, and containers are among the applications that benefit from biopharma plastics’ increased stability. The market has grown due to an increased demand for using premium polymers to manufacture single-use biopharma plastics.

The biopharma plastics and polymers market is anticipated to be driven by rising healthcare costs and health concerns. Additionally, substantial PP molding facilities and the manufacturing industry are anticipated to fuel market expansion throughout the anticipated time frame.

Industry players who are extensively spending in R&D to create biopharmaceutical goods that cater to all customer needs are driving the market for biopharma plastics. Due to the presence of major producers of biopharma plastics, including Celanese Corporation, Eastman Chemical Co., and DuPont, in the region, North America dominates the market for these materials. Due to the expanding governmental support and advantageous reimbursement policies for medical equipment, Europe is the second-largest shareholder in the industry.

Request a Sample of this Report to Understand the Key Dynamics of the Market!

 Key Takeaways from the Market Study

  • As of 2023, the biopharma plastics market was valued at US$ 5.42 billion.
  • From 2023 to 2033, the biopharma plastics industry is poised to grow at an 11.4% CAGR.
  • By 2033, the biopharma plastics market is slated to reach a valuation of US$ 15.95 billion.
  • By polymer type, the polyvinyl chloride segment accounted for the largest share of 21.5% and is expected to continue this trend over the forecast period.
  • China is poised to yield a CAGR of 11.3% with respect to biopharma plastics in 2033.

“Growing healthcare spending and increasing application of biopharma plastics are expected to radically transform the biopharma plastics market in the coming years,” comments an analyst at FMI.

Competitive Landscape

The manufacturers are involved in the production of biopharma plastics in a larger capacity. Research and innovation are also conducted to launch innovative plastics for biopharmaceutical products.

Some of the key players are acquiring small pharmaceutical companies to increase their production capacity.

  • In September 2022, LyondellBasell announced today that Hanwha Solutions Corporation used the LyondellBasell Lupotech T high-pressure polyethylene technology at a new site in Yeosu, South Korea.  The Lupotech T process technology will be used for a 300 kiloton per year (KTA) vinyl acetate copolymer (EVA) line.
  • In July 2022, DuPont celebrated the opening of its new DuPont™Liveo™ Healthcare Solutions manufacturing facility located at the Cooper River Site in South Carolina. The new facility will expand capacity for biopharmaceutical tubing extrusion to meet increased demand from Liveo™ customers
  • In October 2021, Tekni-Plex Healthcare acquired precision extrusion manufacturer Johnson Plastic Group (JPG) as part of a strategy to expand the company’s patient care solutions platform. The acquisition expands Tekni-Plex Healthcare’s medical device capabilities and broadens the division’s global footprint by adding a presence in Mexico.
  • In November 2022, Solvay, a leading supplier of advanced materials, has teamed up with French start-up Ostium in a joint project designed to enable the mechanical recycling of end-of-life single-use surgical instruments molded in glass-fiber reinforced Ixef® polyarylamide (PARA) from Solvay’s portfolio of specialty polymers.

Key Companies Profiled

  • LyondellBasell Industries Holdings B.V.
  • LG Chem
  • Toray Industries Inc.
  • Solvay
  • Dow Inc.
  • DuPont de Nemours Inc.
  • Saint-Gobain Performance Plastics
  • Tekni-Plex
  • Chevron Phillips Chemical Co. Ltd.
  • ExxonMobil Corporation
  • Formosa Plastics Corporation
  • Covestro AG
  • Mitsui & Co. Plastics Ltd.
  • INEOS Group

Request for Research Methodology to Understand Our Data-sourcing Process

More Valuable Insights Available

FMI, in its new offering, presents an unbiased analysis of the biopharma plastics market, presenting historical demand data (2018-2022) and forecast statistics for the period of 2023-2033.

The study divulges essential insights on the Biopharma Plastics Market by Polymer Type (Polyethylene – PE, Polypropylene – PP, Acrylonitrile Butadiene Styrene – ABS, Polyethylene Terephthalate – PET, Polyvinyl Chloride – PVC, Polytetrafluoroethylene – PTFE, Other) by Application (Protective wear, Container, Bioreactor Bags, Syringes, Depth Filter, Disposable Medical Connectors, and Others) and Region.

Key Segments Covered in the Biopharma Plastics Market Industry Survey

By Polymer Type

  • Polyethylene – PE
  • Polypropylene – PP
  • Acrylonitrile Butadiene Styrene – ABS
  • Polyethylene Terephthalate – PET
  • Polyvinyl Chloride – PVC
  • Polytetrafluoroethylene – PTFE
  • Others

By Application

  • Protective Wear
  • Container
  • Bioreactor Bags
  • Syringes
  • Depth Filter
  • Disposable Medical Connectors
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa


Seize Growth Opportunities with our Actionable Insights.

FMI’s Domain Knowledge in Chemicals & Materials

Our chemical & material consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the industrial automation sector.

Our expertise in recognizing the challenges and trends impacting the global chemical & material industry provides indispensable insights and support – encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.

About the Author

Nikhil Kaitwade (Associate Vice President at Future Market Insights, Inc.) has over a decade of experience in market research and business consulting. He has successfully delivered 1500+ client assignments, predominantly in Automotive, Chemicals, Industrial Equipment, Oil & Gas, and Service industries.

His core competency circles around developing research methodology, creating a unique analysis framework, statistical data models for pricing analysis, competition mapping, and market feasibility analysis. His expertise also extends wide and beyond analysis, advising clients on identifying growth potential in established and niche market segments, investment/divestment decisions, and market entry decision-making.

Have a Look at Latest Reports of Chemicals & Materials Domain

Bio-plastics Market Size: Bioplastics are those plastic materials that are manufactured by using natural resources. There are two categories of these plastics available in the market – biodegradable bioplastics and non-biodegradable bioplastics.

Automotive Plastics Market Share: The automotive plastics market globally reached US$ 65.6 billion in 2022. Demand for automotive plastics saw a 6.6% year-on-year growth in 2022, suggesting an expansion of the global market to US$ 70.2 billion in 2023.

Conductive Plastics Market Demand: The global conductive plastics market was valued at US$ 3 Billion in 2021, and is forecast to reach US$ 7.91 Billion by 2032. The expected forecast CAGR from 2022 to 2032 is 8.5%. As of 2022, the market is expected to be valued at US$ 3.5 billion.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us

Nandini Singh Sawlani 

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: [email protected]
LinkedInTwitterBlogs | YouTube

The post Biopharma Plastics Market Expected to Develop at a CAGR of 11.4% through 2033, totaling US$ 15.95 billion | Future Market Insights Inc. appeared first on Future Market Insights.

Original Source of the original story >> Biopharma Plastics Market Expected to Develop at a CAGR of 11.4% through 2033, totaling US$ 15.95 billion | Future Market Insights Inc.